Related Experiment Video
Updated: Jul 17, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Predicting COVID-19 prognosis in hospitalized patients based on early status
David Natanov1, Byron Avihai1, Erin McDonnell1
1Rutgers Robert Wood Johnson Medical School , Piscataway, New Jersey, USA.
Insights
Predicting COVID-19 patient outcomes is crucial. New models using age and lab tests offer a simple, efficient way to assess prognosis and guide critical care decisions.
Area of Science:
- Medical Prognostics
- Infectious Disease Epidemiology
- Health Resource Management
Background:
- COVID-19 is a leading cause of death, necessitating effective patient risk stratification.
- Efficient allocation of critical care resources (ventilators, ICU beds) is vital during surges.
- Accurate prognosis aids clinicians in managing patient care and difficult conversations.
Purpose of the Study:
- To develop and validate predictive models for COVID-19 patient mortality risk.
- To create tools that utilize readily available clinical data for rapid risk assessment.
- To support clinical decision-making and resource management in COVID-19 care.
Main Methods:
- Development of the PLABAC and PRABLE predictive models.
- Utilized patient age and five common laboratory test results as input variables.
- Validated model generalizability across diverse external patient populations in the US.
Main Results:
- The PLABAC and PRABLE models accurately predict COVID-19 patient risk of death.
- Models require only basic demographic and laboratory data for prognosis.
- Demonstrated consistent performance and generalizability in external validation cohorts.
Conclusions:
- PLABAC and PRABLE provide practical, efficient tools for assessing COVID-19 prognosis.
- These models can serve as real-time aids for clinicians discussing patient outcomes.
- The models facilitate better communication and resource allocation for COVID-19 patients.
Importance:
COVID-19 remains the fourth leading cause of death in the United States. Predicting COVID-19 patient prognosis is essential to help efficiently allocate resources, including ventilators and intensive care unit beds, particularly when hospital systems are strained. Our PLABAC and PRABLE models are unique because they accurately assess a COVID-19 patient's risk of death from only age and five commonly ordered laboratory tests. This simple design is important because it allows these models to be used by clinicians to rapidly assess a patient's risk of decompensation and serve as a real-time aid when discussing difficult, life-altering decisions for patients. Our models have also shown generalizability to external populations across the United States. In short, these models are practical, efficient tools to assess and communicate COVID-19 prognosis.
More Related Videos
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Comparing the Survival Analysis of Two or More Groups
Steps in Outbreak Investigation
Cancer Survival Analysis